U.S. markets closed

La Jolla Pharmaceutical Company (LJPC)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.35-0.32 (-5.56%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 1/9/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 2.84
52-Week Change 3-30.52%
S&P500 52-Week Change 313.47%
52 Week High 39.38
52 Week Low 33.36
50-Day Moving Average 34.51
200-Day Moving Average 34.23

Share Statistics

Avg Vol (3 month) 3868.92k
Avg Vol (10 day) 35.21M
Shares Outstanding 527.38M
Float 12.75M
% Held by Insiders 11.46%
% Held by Institutions 188.00%
Shares Short (Dec 30, 2020) 42.85M
Short Ratio (Dec 30, 2020) 413.34
Short % of Float (Dec 30, 2020) 415.23%
Short % of Shares Outstanding (Dec 30, 2020) 410.41%
Shares Short (prior month Nov 29, 2020) 42.78M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:50
Last Split Date 3Jan 13, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020


Profit Margin -205.85%
Operating Margin (ttm)-145.93%

Management Effectiveness

Return on Assets (ttm)-23.58%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)29.72M
Revenue Per Share (ttm)1.09
Quarterly Revenue Growth (yoy)59.00%
Gross Profit (ttm)20.66M
EBITDA -41.11M
Net Income Avi to Common (ttm)-61.18M
Diluted EPS (ttm)-2.24
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)27.76M
Total Cash Per Share (mrq)1.01
Total Debt (mrq)126.66M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)2.25
Book Value Per Share (mrq)-3.27

Cash Flow Statement

Operating Cash Flow (ttm)-47.49M
Levered Free Cash Flow (ttm)-28.32M